The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)
About This Opportunity
United States procurement, healthcare: The Experimental Therapeutics Clinical Trials. Issued by National Institutes of Health. Submission deadline Jun 2026.
This is a grants contract in the health and medical services sector. Located in United States, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before June 30, 2026.
Published through Grants.gov, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for grants in the health and medical services sector. Grant applications generally require a detailed project proposal, a clear results framework, and evidence of the applicant's capacity to deliver the proposed activities. Interested parties should review the full documentation on the original source before submitting their proposal.
Description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain or establish a Pharmacokinetics Resource Laboratory (PK Laboratory) to support the Experimental Therapeutics Clinical Trials Network (ETCTN). The PK Laboratory will organize biospecimen collections and provide subsequent analyses of pharmacokinetic endpoints, drug-drug interactions, cytochrome P450 (CYP) interactions, pharmacodynamics, and food effects in ETCTN studies of NCI Investigational New Drug (IND) agents. The overarching goal of the ETCTN PK Laboratory is to advance the clinical development of NCI IND agents by providing a comprehensive understanding of pharmacokinetic behavior of these agents under study in ETCTN trials. The ETCTN PK Laboratory will engage physicians, clinical pharmacologists, nurses, and scientists who have appropriate expertise in pharmacokinetic studies for early drug development and translational research. This NOFO seeks U24 applications from multidisciplinary institutions/organizations to conduct all pharmacokinetic studies for ETCTN early phase clinical trials filed to IND applications in the NCI Division of Cancer Treatment and Diagnosis (DCTD), Cancer Therapy Evaluation Program (CTEP).
Agency: National Institutes of Health
CFDA: 93.395
Eligible Applicants: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Applicant Types: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; For profit organizations other than small businesses; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Public and State controlled institutions of higher education
Cost Sharing: No
Contact: National Institutes of Health
Email: Email: NCIETCTNRFA@mail.nih.gov
Data provenance
This notice is sourced from Grants.gov and was originally published on May 8, 2026. Last refreshed 8 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About National Institutes of Health
National Institutes of Health has issued 79 procurement notices on BidsFactory, including 77 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for United States. Notices are distributed via Grants.gov. Most recent publication: June 16, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Grants contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Where will the contract be performed?
The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Grants.gov to access the full notice, required documents, and submission instructions provided by the contracting authority.
When does this tender close?
The submission deadline is June 30, 2026. You have 4 days left to prepare and submit your proposal to the contracting authority.
Who is the contracting authority?
This notice was issued by National Institutes of Health in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Key Details
Contracting Authority
Contact
Companies That Won Similar
Companies with awards in Health & Medical in United States